ZFP91-CNTF

Across TCGA pan-cancer cohorts, ZFP91-CNTF RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated ZFP91-CNTF data layer.

The strongest signal is observed in mesothelioma (MESO), where higher ZFP91-CNTF RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZFP91-CNTF expression acts as an unfavorable survival marker, although some lineages such as COAD and UCS show a favorable association.

MESO, ACC, and KICH are the cancer types where ZFP91-CNTF RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Median	All	0.235	0.611	.002	83	view →
ACC	DFS	Median	IV	0.101	0.582	<.001	55	view →
KICH	OS	Median	III,IV	0.533	0.934	.002	39	view →
COAD	OS	Quartile	II,III,IV	0.761	0.540	.008	29	view →
UCS	OS	Median	II,III,IV	0.579	0.272	.014	26	view →
ESCA	DFS	Quartile	III,IV	0.239	0.498	<.001	24	view →
LGG	OS	Median	All	0.743	0.871	<.001	23	view →
THCA	OS	Tertile	III,IV	0.317	0.975	.007	22	view →
LIHC	DFS	Median	All	0.473	0.587	.011	19	view →
READ	DFS	Median	All	0.817	0.626	.018	17	view →
UVM	DFS	Median	All	0.288	0.610	.024	16	view →
DLBC	OS	Quartile	IV	0.172	0.802	.014	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

ZFP91-CNTF–MESO (DFS)

Open the MESO breakdown →